Policy & Regulation
BeOne Medicines' sonrotoclax receives FDA Breakthrough Therapy Designation for MCL
13 October 2025 - Oncology company BeOne Medicines Ltd (NASDAQ:ONC) (HKEX:06160) (SSE:688235) announced on Monday that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Design...
Biophytis and Asian consortium to fund first Phase 3 trial in sarcopenia
13 October 2025 - Clinical-stage biotechnology company Biophytis SA (Euronext Growth Paris:ALBPS) (OTC:BPTSY) said on Monday that it has signed a Memorandum of Understanding with a consortium of inves...
Aptamer Group secures GBP112,000 contract with top 10 global pharmaceutical company
13 October 2025 - Synthetic binders developer Aptamer Group plc (AIM: APTA) declared on Monday that it has signed a GBP112,000 fee-for-service development contract with a top 10 global pharmaceutical ...
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
13 October 2025 - IP Group plc (LSE: IPO), an investor in breakthrough science and innovation companies, on Monday outlined potential future royalty income linked to obesity drug candidates developed ...
Dubai Healthcare City Authority Launches AED 1.3 Billion Expansion Plan to Boost Innovation and Sustainability
13 October 2025 - Dubai Healthcare City Authority (DHCA) has revealed an ambitious AED 1.3 billion development plan for Phase 1 of Dubai Healthcare City (DHCC), reaffirming its position as one of the ...
Jubilant HollisterStier's Washington facility launches new high-speed isolator based Line
13 October 2025 - India-based pharmaceutical company Jubilant Pharmova Limited announced on Friday that its subsidiary Jubilant HollisterStier LLC (JHS), a North American pharmaceutical contract manuf...